Filing Details
- Accession Number:
- 0001213900-23-041328
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-19 08:30:11
- Reporting Period:
- 2023-05-18
- Accepted Time:
- 2023-05-19 08:30:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1690080 | 180 Life Sciences Corp. | ATNF | Pharmaceutical Preparations (2834) | 813832378 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1834681 | Ozan Pamir | 3000 El Camino Real, Bldg. 4, Suite 200 Palo Alto CA 94306 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-05-18 | 5,162 | $1.01 | 8,983 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $0.9801 to $1.02, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.